following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people..
researchers have developed a new artificial intelligence-based software which may identify and measure the severity of common causes of strokes and.
. sections
.
. .